Navigation Links
Jan Marini Skin Research Suspends Sales of Popular Eyelash Products

SAN JOSE, Calif., Jan. 17 /PRNewswire/ -- Jan Marini Skin Research, Inc. (JMSR; today announced that it will voluntarily suspend the sale of its Age Intervention Eyelash Conditioner and Age Intervention Masses of Lashes Mascara products in the U.S.

JMSR cited a patent infringement lawsuit by Allergan Pharmaceutical as one reason for the suspension. "We believe that it makes sense to suspend these products while we strategically review our options," said JMSR President & CEO Jan Marini. "We are assured that the Allergan allegations are unfounded. However, the lawsuit is a major distraction."

JMSR reasserted its confidence in the safety profile of the products, and noted that it has conducted numerous and excellent safety studies. The company maintains its legal right to market both products.

"While these two products have been overwhelmingly popular, JMSR's core skin care products remain the foundation of our business success," said Marini. "Our marketplace is incredibly loyal and supportive. We are preparing to launch new products and are very excited about 2008."

About Jan Marini Skin Research, Inc.

San Jose, CA-based Jan Marini Skin Research, Inc. is a recognized leader and innovator in skin care, providing state of the art technologies and breakthroughs in medically-based skin care therapies. JMSR Skin Care Management System is used and trusted by physicians and skin care professionals worldwide to ensure optimum results for their patients and clients. Products range from Glycolic Acid formulas and patented breakthroughs to the state-of-the-art anti-aging properties of the remarkable C-ESTA(R) family of products, all aimed at addressing aging skin, acne, rosacea and other common skin concerns. For more information, please visit

Contact: Megan Meece Mark Marinovich

Zing USA Jan Marini Skin Research, Inc.

(212) 633-6301 (408) 362-0130, Ext. 325

SOURCE Jan Marini Skin Research, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jan Marini Skin Research Adds Two New Sheer Colors to Antioxidant Daily Face Protectant SPF 30 With PhytoMelanin(TM)
2. Jan Marini Skin Research Gives Familiar Logo a Facelift
3. Stanford researchers find culprit in aging muscles that heal poorly
4. Children of depressed moms do better when dad is involved, SLU researcher finds
5. UCLA researchers identify markers that may predict diabetes in still-healthy people
6. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
7. New research shows how chronic stress worsens neurodegenerative disease course
8. New research explores newborn in-hospital weight loss
9. Research may unlock mystery of autisms origin in the brain
10. Bipolar disorder relapses halved by Melbourne researchers
11. HIVs impact in Zimbabwe explored in new research
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: